Friday, January 30, 2026

Will the NCG Stand Strong? Future of U.S.-South Korea Nuclear Strategy Uncertain

The Nuclear Consultative Group is expected to endure under a potential Trump administration, despite concerns over its effectiveness.

South Korea’s Cheonan Frigate Named ‘Top-Gun of the Sea’ – Here’s Why It’s the Navy’s Best Combat Ship

The South Korean Navy's Cheonan frigate is named the best gunnery combat ship, showcasing exceptional skills and teamwork in evaluations.

STOP THE WAR GAMES! North Korea Fires Missile and Demands US Cease Exercises Immediately—Or ELSE!

The U.S. and South Korea conduct joint military exercises, prompting North Korea to threaten aggressive responses to perceived threats.

Tag: drug

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

Yuhan’s Leclaza and J&J’s Rybrevant: How This Cancer Combo Surged Past 1 Billion USD in Sales

Sales of Yuhan's lung cancer drug 'Lazertinib' and J&J's 'Amivantamab' exceeded 1 trillion won last year.

Korea Clears New Probiotic Claim: hy’s HY7017 Shows Immune Gains in Human Trials

hy's probiotic strain HY7017 has been approved for immune enhancement, adding to its portfolio of nine recognized ingredients.

JW Pharmaceutical Secures U.S. Patent for Hair Loss Drug Candidate JW0061

JW Pharmaceutical secures a U.S. patent for hair loss treatment JW0061, targeting GFRA1 receptor, ensuring market exclusivity until 2039.

Samsung Bioepis Secures U.S. Approval for Pen-Style Stelara Biosimilar, Setting a Market First

Samsung Bioepis receives FDA approval for Epyztek, the first pre-filled pen for autoimmune treatments, enhancing patient convenience.

Patches, Implants, and Oral Films… The Drug-Delivery Format Battle After Oral Wegovy

Oral Wegovy's launch is transforming obesity treatment, focusing on user-friendly delivery methods and enhancing patient adherence.

Celltrion’s Eydenzelt: How Strategic Patent Agreements Enable U.S. and European Market Entry in 2026

Celltrion's Eydenzelt secures global distribution via strategic patent agreements, aiming for swift market entry in the U.S. and Europe.

The Easiest Way To Lose Investor Trust? Just Steal $6.7 Billion! BMS Masterclass In Bad Business

Bristol Myers Squibb faces a $6.7B lawsuit over alleged delays in drug approvals affecting former Celgene shareholders' payouts.

New Obesity Pill Could End Wegovy’s Reign, Offering Faster and Safer Results

Ildong's ID110521156 shows promise as an affordable GLP-1 obesity drug with fewer side effects, aiming to transform the treatment landscape.

This New Drug Could Stop Kidney Failure After Heart Surgery

Bilix receives MFDS approval for Phase 2a trial of Brixelle, targeting acute kidney injury in cardiac surgery patients.

No Batteries Needed: These Microscopic Robots Run on Urea

KAIST develops a self-propelled cell robot powered by urea, enabling autonomous movement for targeted transport and environmental modulation.

Samsung Launches New Mini-Organ Tech to Speed Up Cancer Drug Testing

Samsung Biologics launches Samsung Organoids for drug screening, focusing on anticancer candidates to enhance precision and reduce costs.

Novo Nordisk and Lilly Block Generics, Tighten Grip on $125B GLP-1 Market

Novo Nordisk and Eli Lilly secure court victories against generics, maintaining dominance in the GLP-1 treatment market amid rising demand.

New Drug Candidate Shows Promise Against Solid Tumors by Eliminating M2 Macrophages

Researchers have developed a peptide drug that targets M2 macrophages, enhancing solid tumor immunotherapy effectiveness.

Safe Medication Use During Pregnancy: What You Need to Know

Expectant mothers should consult healthcare providers about medication use during pregnancy to ensure safety for both mother and baby.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.